Cathay International Holdings Limited (CIH) is an investment holding company. CIH is an investor in the healthcare sector in People�s Republic of China. The Company's products and services line includes the Lansen Group segment, which is focused on the manufacture, marketing and sale of specialty western pharmaceuticals, modern Chinese medicine extracts and generic pharmaceuticals in the People�s Republic of China, and the Haotian Group segment, which is involved in the manufacture, marketing and sale of ingredients for healthcare products, including inositol. The research and development segment is engaged in the development of pharmaceutical products, and the hotel operations segment, in which the Company had a hotel located in the Lowu district of Shenzhen in the People�s Republic of China. The Company also has a private equity investment arm focused on minority investment opportunities and a hotel investment.